Biocryst Pharmaceuticals (BCRX) Other Accumulated Expenses (2011 - 2021)
Biocryst Pharmaceuticals' Other Accumulated Expenses was $3.68 million in Q4 2021, down 83.0% from $21.67 million a year earlier and down 85.6% from the prior quarter.
Powered by 
Analysis
Biocryst Pharmaceuticals (BCRX) Other Accumulated Expenses (2011 - 2021) Analysis & Trends
From Q2 2011 onward, Biocryst Pharmaceuticals has reported Other Accumulated Expenses for 38 quarters.
- Other Accumulated Expenses shows a five-year compound annual growth rate of -16.4% (FY2016 to FY2021).
- In earlier years, Other Accumulated Expenses was $21.67 million in FY2020 (+45.4%), $14.9 million in FY2019 (+25.8%), $11.85 million in FY2018 (-2.0%) and $12.1 million in FY2017 (+34.5%).
- The Q4 2021 figure marks the lowest quarterly Other Accumulated Expenses since Q3 2013.
- Compared with a year earlier, Other Accumulated Expenses was higher in five of the last six quarters, with growth averaging 17.4%.
- The best year-over-year quarter for Other Accumulated Expenses over five years was Q4 2020 (growth of 45.4%); the worst was Q4 2021 (a decline of 83.0%).
- Per Business Quant data, BCRX's Other Accumulated Expenses in the three quarters before Q4 2021 was $25.55 million (Q3 2021), $25.22 million (Q2 2021) and $23.55 million (Q1 2021).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Biocryst Pharmaceuticals | 2.09 Bn | 1.01 Bn | 214.41 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2021 | 3.68 Mn |
| Sep 30, 2021 | 25.55 Mn |
| Jun 30, 2021 | 25.22 Mn |
| Mar 31, 2021 | 23.55 Mn |
| Dec 31, 2020 | 21.67 Mn |
| Sep 30, 2020 | 19.30 Mn |
| Mar 31, 2020 | 16.38 Mn |
| Dec 31, 2019 | 14.90 Mn |
| Sep 30, 2019 | 13.42 Mn |
| Jun 30, 2019 | 14.75 Mn |
| Mar 31, 2019 | 13.39 Mn |
| Dec 31, 2018 | 11.85 Mn |
| Sep 30, 2018 | 10.43 Mn |
| Jun 30, 2018 | 14.83 Mn |
| Mar 31, 2018 | 13.47 Mn |
| Dec 31, 2017 | 12.10 Mn |
| Sep 30, 2017 | 10.71 Mn |
| Jun 30, 2017 | 11.59 Mn |
| Mar 31, 2017 | 10.29 Mn |
| Dec 31, 2016 | 8.99 Mn |
API Access
Biocryst Pharmaceuticals Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=BCRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "BCRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=BCRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();